Table 1.
CRISPR-Cas systems |
||||
---|---|---|---|---|
Presence (n = 40) |
Absence (n = 57) | p-Value | ||
Type I-E | Subtype I-E∗ | |||
(n = 23) | (n = 17) | |||
Chromosome size (bp) | 5,354,756 (62,628) | 5,339,573 (75,216) | 5,346,821 (116,544) | 0.761, 0.810, 0.507a |
Plasmid count | 3.52 (2.020) | 1.71 (1.448) | 3.02 (1.758) | 0.269, 0.007, 0.003a |
Phage count | 5.39 (2.888) | 3.18 (1.741) | 6.11 (3.063) | 0.341, <0.001, 0.008a |
Spacer number | 36.5 (11.7) | 21.3 (4.6) | – | <0.001b |
Number of spacer hit plasmids | 3.09 (1.6) | 3.65 (1.9) | – | 0.318 |
Presence of antibiotic resistance genesc | ||||
Aminoglycoside | 18 (78.3) | 8 (47.1) | 44 (77.2) | 0.039d |
β-Lactam | 15 (65.2) | 8 (47.1) | 43 (75.4) | 0.084d |
Fluoroquinolones | 17 (73.9) | 7 (35.3) | 36 (63.2) | 0.103d |
MLS | 2 (8.7) | 6 (32.3) | 23 (40.4) | 0.022d |
Rifampicin | 2 (8.7) | 2 (11.8) | 4 (7.0) | 0.816d |
Phenicols | 5 (21.7) | 12 (70.6) | 29 (50.9) | 0.260d |
Sulfonamide | 14 (60.9) | 7 (35.3) | 36 (63.2) | 0.264d |
Tetracycline | 10 (43.5) | 3 (17.6) | 15 (26.3) | 0.164d |
Trimethoprim | 14 (60.9) | 6 (32.3) | 32 (56.1) | 0.231d |
ap-Values were shown as CRISPR-negative strains vs. type I-E strains, CRISPR-negative strains vs. subtype I-E∗ strains, and type I-E strains vs. subtype I-E∗ strains.
bp-Value was shown as type I-E strains vs. subtype I-E∗ strains.
cOnly antibiotic resistance genes presented in the plasmid were considered (acquired resistance).
dp-Value was determined by the distribution of antibiotic resistance genes among three groups.
Values were expressed as mean (SD), unless otherwise indicated as number (percent).
MLS, Macrolides, lincosamides, and streptogramines.
The Student’s t-test was applied for all the parametric difference between three groups, and Pearson’s chi-square test was used for the difference in the presence of antibiotic resistance genes between three groups.
Statistically significant correlations (p < 0.05) are shown in bold font.